相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Utilizing adenovirus vectors for gene delivery in cancer
Dayananda Kasala et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Current strategies for designing antidotes against botulinum neurotoxins
Kruti Patel et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection
Irina L. Tutykhina et al.
ANTIVIRAL RESEARCH (2013)
Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin
David J. Vance et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Nanobodies and their potential applications
Gholamreza Hassanzadeh-Ghassabeh et al.
NANOMEDICINE (2013)
Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein
Q. Meng et al.
ANALYTICAL BIOCHEMISTRY (2012)
A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model
Jean Mukherjee et al.
PLOS ONE (2012)
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins
Alejandro Lopez-Requena et al.
FRONTIERS IN ONCOLOGY (2012)
Strategies for extended serum half-life of protein therapeutics
Roland E. Kontermann
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Hepatocyte-Targeted Expression by Integrase-Defective Lentiviral Vectors Induces Antigen-Specific Tolerance in Mice with Low Genotoxic Risk
Janka Matrai et al.
HEPATOLOGY (2011)
Pharmacological Interventions for Improving Adenovirus Usage in Gene Therapy
Hidde J. Haisma et al.
MOLECULAR PHARMACEUTICS (2011)
Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding Agents
Jorge Sepulveda et al.
INFECTION AND IMMUNITY (2010)
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance
Andrea Annoni et al.
BLOOD (2009)
Adenovirus-Mediated Delivery of an Anti-V Antigen Monoclonal Antibody Protects Mice against a Lethal Yersinia pestis Challenge
Carolina Sofer-Podesta et al.
INFECTION AND IMMUNITY (2009)
Immunological applications of single-domain llama recombinant antibodies isolated from a naive library
Ana Monegal et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy
Chantal Zuber et al.
JOURNAL OF GENERAL VIROLOGY (2008)
A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells
Jeffrey S. Smith et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV
Bishnu P. De et al.
MOLECULAR THERAPY (2008)
Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV
Davor Skaricic et al.
VIROLOGY (2008)
An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo
Jianmin Fang et al.
MOLECULAR THERAPY (2007)
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Jinyong Luo et al.
NATURE PROTOCOLS (2007)
Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers
Minghong Jiang et al.
CLINICAL CANCER RESEARCH (2006)
Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation
Peter Verheesen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin
Allen Nguyen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Stable antibody expression at therapeutic levels using the 2A peptide
JM Fang et al.
NATURE BIOTECHNOLOGY (2005)
Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody
K Kasuya et al.
MOLECULAR THERAPY (2005)
Antitoxins: Novel strategies to target agents of bioterrorism
GJA Rainey et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2004)
Pharmacokinetics and biodistribution of genetically engineered antibodies
SK Batra et al.
CURRENT OPINION IN BIOTECHNOLOGY (2002)
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer
AD Lewis et al.
JOURNAL OF VIROLOGY (2002)
Passive antibody administration (immediate immunity) as a specific defense against biological weapons
A Casadevall
EMERGING INFECTIOUS DISEASES (2002)
High in vivo production of a model monoclonal antibody on adenoviral gene transfer
D Noël et al.
HUMAN GENE THERAPY (2002)
High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector
K Morimoto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
NJ Tao et al.
MOLECULAR THERAPY (2001)
Production of first generation adenovirus vectors: a review
X Danthinne et al.
GENE THERAPY (2000)
Improvements in adenoviral vector technology: overcoming barriers for gene therapy
RJ Parks
CLINICAL GENETICS (2000)
Adenovirus technology for gene manipulation and functional studies
YB Wang et al.
DRUG DISCOVERY TODAY (2000)
分享论文
